Acotec Scientific Holdings Limited (ACOTEC-B) filed its Monthly Return with Hong Kong Exchanges and Clearing on 3 June 2026, covering movements in securities for the month ended 31 May 2026.

The company’s authorised share capital remained unchanged at 10.00 billion ordinary shares with a par value of USD 0.00001 each, equivalent to total authorised capital of USD 100,000.

Issued share capital was steady at 313.39 million ordinary shares. No new shares were issued, repurchased or cancelled, and the company held no treasury shares at month-end.

Acotec Scientific confirmed compliance with the Main Board’s minimum public-float requirement of 25%, indicating that the proportion of shares held by the public continues to meet Hong Kong Stock Exchange rules.

No share options, warrants, convertibles, or other equity instruments were exercised, issued or transferred during the period. The company’s Restricted Share Unit Scheme (adopted 8 January 2021) and Share Award Scheme (adopted 31 December 2021) recorded no activity in May.

Overall, Acotec Scientific’s capital structure and share count were unchanged during the month, reflecting a period of stability in its equity base.